Prevention & Chronic Conditions

Category icon
Dyslipidaemia in the Real World

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk, et al

Category icon
APSC Consensus on Optimising CV Outcomes in T2D

Jack Wei Chieh Tan, David Sim, Junya Ako, et al

Category icon
Inflammation in Coronary Epicardial and Microvascular Dysfunction

Shigeo Godo, Jun Takahashi, Satoshi Yasuda, et al

Category icon
Type 2 Diabetes Treatment in Patients with CVD

Tariq Ahmad, Ralph J Riello, Silvio Inzucchi,

Category icon
Editorial: The EXCEL Trial

Pablo Avanzas, Juan Carlos Kaski,

Category icon
Renin–Angiotensin–Aldosterone System and COVID-19

Eliecer Coto, Pablo Avanzas, Juan Gómez,

Category icon
Bridging the Gap in a Rare Cause of Angina

Sumanth Khadke, Jovana Vidovic, Vinod Patel,

Category icon
Pharmacotherapy in Stable CAD: The ISCHEMIA Trial

Jonathan Yap, Derek P Chew, Gregg W Stone, et al

Category icon
Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist, Helmut Pürerfellner, Alex White, et al

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Related Articles

Articles

Article icon
Dyslipidaemia in the Real World

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk,

Published:

Citation: European Cardiology Review 2021;16:e16.

Anti-inflammatory Treatment and Cardiovascular Outcomes

Alberto Lorenzatti,

Published:

Citation: European Cardiology Review 2021;16:e15.

APSC Consensus on Optimising CV Outcomes in T2D

Jack Wei Chieh Tan, David Sim, Junya Ako,

Published:

Citation: European Cardiology Review 2021;16:e14.

Inflammation in Coronary Epicardial and Microvascular Dysfunction

Shigeo Godo, Jun Takahashi, Satoshi Yasuda,

Published:

Citation: European Cardiology Review 2021;16:e13.